Assessment of antibiotic susceptibility of Ureaplasma urealyticumfrom prostitutes and outpatient clinic patients using the E-test and agar dilution method

Chemotherapy

Volumn 49, Issue 1-2, 2003, Pages 39-43

  Çakan, Hüseyin ^a,b   Polat, Erdal ^b   Kocazeybek, Bekir ^b   Öcal, Pelin ^b   Çepni, Ismail ^b   Aslan, Mustafa ^b   Salihoǧlu, Funda ^b   Altaş, Kemal ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Agar dilution method; Antibiotic susceptibility; E test; Ureaplasma urealyticum

Indexed keywords

AGAR; ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; OFLOXACIN; ROXITHROMYCIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DILUTION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL; PROSTITUTION; UREAPLASMA UREALYTICUM; VAGINA DISCHARGE;

ANTI-INFECTIVE AGENTS; COLONY COUNT, MICROBIAL; COMORBIDITY; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS; OUTPATIENTS; PROSTITUTION; SPECIES SPECIFICITY; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM; VAGINA;

EID: 0037265943     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069781     Document Type: Article

References (17)

1. Yücel A, Polat E, Çepni I, Öztas Ö., Esen AF: Determination of frequency of M. hominis and Ureaplasma urealyticum by cultural method in vaginal secretions obtained from prostitutes and from women evaluated at routine outpatient clinic. FEMS Symposium Program and Abstracts, 1998, pp 6-36.
2. Pannekoek Y, Trum JW, Bleker OP, van der Veen F, Spanjaard L, Dankert J: Cytokine concentrations in seminal plasma from subfertile men are not indicative of the presence of Ureaplasma urealyticum or Mycoplasma hominisin the lower genital tract. J Med Microbiol 2000; 49:697-700.
3. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Washington CW Jr: Mycoplasmas and Ureaplasmas. Color Atlas and Textbook of Diagnostic Microbiology, ed 4. Philadelphia, J.B. Lippincott, 1992, pp 675-698.
4. Clyde WA, Kenny GE, Schacherter J: Laboratory diagnosis of Chlamydia and Mycoplasmal infections. Cumulative Tech Proced Clin Microbiol 1984;19:1-19.
5. Abele-Horn M, Blendinger C, Becher C, Emmerling P, Ruckdeschel G: Evaluation of commercial kits for quantitative identification and tests on antibiotic susceptibility of genital mycoplasmas. Zentralbl Bacteriol 1996;284:540-549.
6. Potasman I, Oren A, Srugo I: Isolation of Ureaplasma urealyticum and Mycoplasma hominis from public toilet bowls. Infect Control Hosp Epidemiol 1990;20:66-68.
7. Broitman NL, Floyd CM, Johnson CA, de la Maza LM, Peterson EM: Comparison of commercially available media for detection and isolation of Ureaplasma urealyticum and Mycoplasma hominis. J Clin Microbiol 1992;30:1335-1337.
8. Moller BR, Herrmann B, Ibsen HH, Halkier-Sorensen L, From E, Mardh PA: Occurrence of Ureaplasma urealyticum and Mycoplasma hominis in non-gonococcal urethritis before and after treatment in a double-blind trial of ofloxacin versus erythromycin. Scand J Infect Dis Suppl 1990;68:31-34.
9. Kenny GE, Cartwright FD: Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin. Antimicrob Agents Chemother 1996;40:1048-1049.
10. Kenny GE, Cartwright FD: Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines. Antimicrob Agents Chemother 1994;38:2628-2632.
11. Van Schouwenburg J, de Bruyn O, Fourie E, van Rensburg J, Rodriques A, Pickard I: A randomized, comparative study of the efficacy and tolerance of roxithromycin and doxycycline in the treatment of women with positive endocervical cultures for Chlamydia trachomatis and Mycoplasma spp. in an in vitro fertilization program. Diagn Microbiol Infect Dis 1992;15: 129-131.
12. Renaudin H, Bebear C: Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis 1990;9:838-841.
13. Rumpianesi F, Morandotti G, Sperning R, Satta G, Cevenini R: In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline. J Chemother 1993;5: 155-158.
14. Rylander M, Hallander HO: In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Scand J Infect Dis Suppl 1998;53:12-17.
15. Waites KB, Cassell GH, Canupp KC, Fernandes PB: In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrob Agents Chemother 1988;32:1500-1502.
16. Rennie KA, Prasad ES, Wenman WM: In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species. Diagn Microbiol Infect Dis 1994;20:57-59.
17. Ogasawara KK, Goodwin TM: Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. J Matern Fetal Med 1999;8:12-16.